SciELO - Scientific Electronic Library Online

 
vol.84 issue3Comparative study of the results of coronary artery bypass grafting and angioplasty for myocardial revascularization in patients with equivalent multivessel diseaseEffects of the prolonged inhibition of the angiotensin-converting enzyme on the morphological and functional characteristics of left ventricular hypertrophy in rats with persistent pressure overload author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

Related links

Share


Arquivos Brasileiros de Cardiologia

Print version ISSN 0066-782X

Arq. Bras. Cardiol. vol.84 no.3 São Paulo Mar. 2005

http://dx.doi.org/10.1590/S0066-782X2005000300005 

ORIGINAL ARTICLE

 

Relation between left atrial dimension and exercise capacity in endomyocardial fibrosis

 

 

Charles Mady; Vera Maria Cury Salemi; Barbara Maria Ianni; Fábio Fernandes; Edmundo Arteaga
São Paulo, SP - Brazil

Instituto do Coração (InCor) - HC - FMUSP

Correspondence

 

 


ABSTRACT

OBJECTIVE: To assess whether exercise capacity is related to left atrial dimension (LAD) in patients with biventricular endomyocardial fibrosis.
METHODS: This study comprised 38 patients in sinus rhythm, with a mean age of 37.5 ± 11.5 years (range, 11 to 59 years), 25 of whom were women. They were divided into 2 groups according to the NYHA functional class on hospital admission as follows: group A (12 patients) and group B (26 patients). All patients underwent cardiopulmonary exercise testing to determine their maximum oxygen consumption (VO2 max), and their left atrial dimension was determined on echocardiography.
RESULTS: The VO2max values for groups A and B were 21.8 ± 4.8 mL.kg–1.min–1 and 13.7 ± 3.5 mL.kg–1.min–1, respectively, and the left atrial dimensions were 3.7±0.7cm and 4.4±0.7cm for groups A and B, respectively. A significant and inverse correlation was found between VO2max and LAD in the groups studied.
CONCLUSION: The increase in left atrial dimension is associated with impairment in exercise capacity in patients with endomyocardial fibrosis. Our findings support the use of left atrial dimension to estimate a more complex and difficult to assess index of functional capacity, such as VO2max.

Key words: left atrial dimension, exercise capacity, endomyocardial fibrosis


 

 

Endomyocardial fibrosis (EMF) is a rare restrictive cardiomyopathy characterized by fibrous thickening of the endocardium and adjacent myocardium. The apex and ventricular inlet are most commonly involved, which often results in obliteration of one or both ventricular cavities1. Usually, the build-up of fibrous tissue extends to the papillary muscles interfering with the anatomy and function of the atrioventricular valvular apparatus. The morphological alterations in the ventricular chambers added to the atrioventricular valvular dysfunction cause a restrictive syndrome, which usually manifests as bilateral, or mainly right ventricular, diastolic heart failure2-6. One of the most important pathophysiological adaptive mechanism is atrial enlargement1,5, which seems to play a fundamental role in maintaining cardiac output. Exercise intolerance, assessed through cardiopulmonary exercise testing, is a fundamental determinant of clinical evolution in patients with heart failure7,8 and reflects much more the alterations in left ventricular diastolic function than in systolic function9. However, cardiopulmonary exercise testing is of limited clinical application in those patients, because most of them have signs and symptoms of advanced heart failure, such as ascites and cardiac cachexia, at the time of diagnosis10.

Considering the restrictive pathophysiological pattern of the disease, we discuss whether left atrial enlargement should be a marker of functional capacity in the mentioned patients. The objective of this study was to investigate the potential association between left atrial dimension and VO2max in patients with endomyocardial fibrosis.

 

Methods

The patients selected had been hospitalized for clinical assessment and treatment of endomyocardial fibrosis and had sinus rhythm with biventricular impairment evidenced on ventriculography. This study comprised 38 patients with a mean age of 37.5±11.5 years (range, 11 to 59 years), 25 of the female sex, divided on hospital admission into 2 groups (A and B) according to the NYHA functional class. Group A comprised 12 patients in functional class I or II, and group B comprised 26 patients in functional class III or IV.

All patients, after being stabilized for heart failure, underwent cardiopulmonary exercise testing to assess maximum oxygen consumption (VO2max, mL.kg-1.min-1). The respiratory variables were obtained under standard conditions of temperature, pressure, and humidity (StPD), applying the appropriate correction factors. Both groups underwent maximum exercise testing based on the modified Naughton protocol 11, using a motorized treadmill (Quinton, model Q65, Seattle, Washington), with variable velocity and tilting.

Commercial echocardiographic equipment was used to assess left atrial dimension (cm). The echocardiographic parameters were determined based on the recommendations of the American Society of Echocardiography12.

All patients signed a written consent to participate in the study after being informed about the objectives and methods used. The procedures performed conformed to institutional ethical guidelines, and the institutional review committee approved the protocol with the principles defined by the Helsinki Declaration.

Pearson correlation coefficient and regression analysis were used to investigate the relation between left atrial dimension and VO2max in each group studied. The correlation coefficient was considered statistically significant when P < 0.05. Tests of parallelism and coincidence between both regression lines were performed for assessing whether the NYHA functional class may influence the potential relation between left atrial dimension and functional capacity. The variables are described in the text as mean ± standard deviation.

 

Results

The values obtained for VO2max were 21.8 ± 4.8 mL.kg-1.min-1 and 13.7 ± 3.5 mL.kg-1.min-1 in groups A and B, respectively. The left atrial dimension was 3.7 ± 0.7 cm in group A and 4.4±0.7 cm in group B.

Figure 1 shows an inverse correlation between VO2max and left atrial dimension for each group studied separately. The regression line obtained for group B (y = 27.4 - 3.1x, P = 0.0017) was shifted downwards (P = 0.0003) and in parallel (P = 0.3727), when compared with the regression line obtained for group A (y = 38.8 - 4.6x, P = 0.0019), indicating a significant interference of functional class in the correlation found between VO2max and left atrial dimension.

 

 

Discussion

Biventricular endomyocardial fibrosis is clinically characterized by predominantly right heart failure, with descending and prominent elevated jugular venous pressure, quiet precordium, third cardiac sound, and usually huge ascites on physical examination. The patients affected usually have a poor evolution, manifested as a high mortality rate within the first years after diagnosis13. Echocardiography performed by experienced professionals is of fundamental importance to confirm the diagnosis in suspicious cases. Normal ventricular cavities or of reduced size with apical obliteration, usually associated with atrioventricular valvular regurgitation and normal or slightly reduced systolic function, are the major characteristics, in addition to an enlarged right or left atrium, or both14. The echocardiography may help in the differential diagnosis with other restrictive syndromes, such as amyloidosis and constrictive pericarditis15. Fibrous tissue builds up in the endomyocardial region in varied degrees, involving one or both ventricles. Clinical evolution has been related to morphological presentation7. In addition, NYHA functional class has been related to survival; therefore, it should be considered in surgical therapeutic decisions7,16.

The present study showed that left atrial dimension is related to VO2max in patients with endomyocardial fibrosis, sinus rhythm, and biventricular impairment. Previous studies 17,18 have reported similar findings in patients with heart failure. As already emphasized, some results have indicated that NYHA functional class interferes with that relation, because the functional class is known to significantly relate to the functional capacity in those patients8. The increase in left atrial dimension is a marker of mortality in the general population and also in patients with myocardial infarction 19. However, the ability for predicting survival based on left atrial dimension should be investigated in patients with endomyocardial fibrosis.

This is the first study indicating an association between a characteristic morphological alteration, represented by left atrial enlargement, and physical capacity impairment in patients with endomyocardial fibrosis. This finding may have prognostic implications, because NYHA functional class has been shown to negatively influence survival. The natural history of patients with endomyocardial fibrosis in functional class I or II is relatively benign as compared with that of patients in functional class III or IV16. However, it is yet to be demonstrated whether the characteristic morphological alterations in that disease, such as ventricular dimension and morphology, influence functional capacity. In addition, it is also necessary to investigate whether our findings can be applied to patients who are not in sinus rhythm and have isolated right or left ventricular impairment.

In patients with dilated cardiomyopathy, left atrial volume has been associated with ventricular remodeling, diastolic dysfunction, and the degree of mitral regurgitation 20. In endomyocardial fibrosis, the enlargement in left atrial dimension may be related to the presence of mitral regurgitation, diastolic dysfunction, or degree of fibrous tissue build-up. The cause of such enlargement should be better investigated.

Previous studies have reported that, in patients without any antecedent of atrial arrhythmias or valvular heart disease, left atrial volume reflects the degree of diastolic dysfunction 21. Diastolic dysfunction is recognized as an important prognostic factor in several heart diseases, and endomyocardial fibrosis is a disease model characterized by that dysfunction 22. However, the indices obtained on Doppler are influenced by multiple factors. In contrast, left atrial dimension is less influenced by acute alterations and reflects the duration and severity of the diastolic dysfunction 23-24.

In patients with endomyocardial fibrosis, the reduction in compliance caused by fibrous tissue build-up leads to an increase in left atrial pressure to maintain adequate left ventricular filling 25. Therefore, the increase in left atrial pressure causes atrial dilation. From the pathophysiological viewpoint, our findings may indicate that the left atrial dimension corresponds to the degree of restriction in ventricular filling, and, therefore, should be an accurate marker of the stage of the disease and reflect the degree of diastolic function impairment. In addition, left atrial dimension has proved to be an important predictor of atrial fibrillation. Previous studies have reported that atrial fibrillation is present in 36.2% of the patients with endomyocardial fibrosis and biventricular or predominantly right ventricular impairment 26. In addition, in these patients, atrial fibrillation is associated with a worse prognosis, but the study showed that surgery potentially reversed that poor evolution.

Our findings allow the use of a morphological parameter, such as left atrial dimension, which is easily obtained on echocardiography, for estimating a more complex and difficult to assess index, such as VO2max.

 

References

1. Connor DH, Somers K, Hutt MSR, Manion WC, D'Arbela PG. Endomyocardial fibrosis in Uganda (Davies' disease). Part II. An epidemiologic, clinical, and pathologic study. Am Heart J 1968;75:107-12.         [ Links ]

2. Brockington IF, Olsen EGJ, Goodwin JF. Endomyocardial fibrosis in Europeans resident in tropical Africa. Lancet 1967;1:583-8.         [ Links ]

3. Olsen EGJ. Restrictive cardiomyopathy. Postgrad Med J 1986;62:607-8.         [ Links ]

4. Mady C, Pereira-Barretto AC, Oliveira SA, Stolf N, Bellotti G, Pileggi F. Evolution of the endocardial fibrotic process in endomyocardial fibrosis. Am J Cardiol 1991; 68:402-3.         [ Links ]

5. Cherian G, Vijayaraghavan G, Krishnaswami S et al. Endomyocardial fibrosis: report on the hemodynamic data in 29 patients and review of the results of surgery. Am Heart J 1983;4:659-66.         [ Links ]

6. Goodwin JF. Endomyocardial disease - clinical features. Postgrad Med J 1983;59: 154-55.         [ Links ]

7. Pereira-Barretto AC, da Luz PL, Oliveira AS et al. Determinants of survival in endomyocardial fibrosis. Circulation 1989;80 (Suppl. I):I-177-I-182.         [ Links ]

8. Mady C, Pereira-Barretto AC, Mesquita ET et al. Maximal functional capacity in patients with endomyocardial fibrosis. Eur Heart J 1993;14:240-2.         [ Links ]

9. Packer M. Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failure. Circulation 1990;81(2 Suppl):III78-86.         [ Links ]

10. Salemi VMC, Mady C. Aspectos clínicos e fatores prognósticos em pacientes com endomiocardiofibrose. Rev Soc Cardiol Estado de São Paulo 2003;13: 509-15.         [ Links ]

11. Naughton J, Balke B, Nagle F. Refinement in methods of evaluation and physical conditionning before and after myocardial infarction. Am J Cardiol 1964;14:837-43.         [ Links ]

12. Sahn DJ, DeMaria AN, Kisslo J, Weyman A. The Committee on M-mode Standartization of the American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-83.         [ Links ]

13. D'arbela PG, Mutazindwa T, Patel AK, Somers K. Survival after first presentation with endomyocardial fibrosis. Br Heart J 1972;34:403-7.         [ Links ]

14. Brindeiro Filho D, Cavalcanti C. O valor do EcoDopplercardiograma na identificação diagnóstica e no manuseio da endomiocardiofibrose. Arq. Bras. Cardiol 1996;67:279-84.         [ Links ]

15. Acquatella H, Schiller NB, Puigbó JJ, Gómez-Mancebo JR, Suarez C, Acquatella G. Value of two-dimensional echocardiography in endomyocardial disease with and without eosinophilia. A clinical and pathologic study. Circulation 1983;67:1219-26.         [ Links ]

16. Mady C, Pereira-Barretto AC, Oliveira AS et al. Effectiveness of operative and nonoperative therapy in endomyocardial fibrosis. Am J Cardiol 1989;63:1281-2.         [ Links ]

17. Ceresa M, Capomolla S, Pinna GD et al. Left atrial function: bridge to central and hormonal determinants of exercise capacity in patients with chronic heart failure. Monaldi. Arch Chest Dis 2002;58:87-94.         [ Links ]

18. Triposkiadis F, Trikas A, Pitsavos C, Papadopoulos P, Toutouzas P. Relation of exercise capacity in dilated cardiomyopathy to left atrial size and systolic function. Am J Cardiol 1992;15;70:825-7.         [ Links ]

19. Moller JE, Hillis GS, Oh JK et al. Left atrial volume: a powerful predictor of survival after acute myocardial infarction. Circulation 2003 6;107:2207-12.         [ Links ]

20. Rossi A, Cicoira M, Zanolla L et al. Determinants and prognostic value of left atrial volume in patients with dilated cardiomyopathy. J Am Coll Cardiol 2002;40:1425-30.         [ Links ]

21. Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 2002;90:1284-9.         [ Links ]

22. Salemi VMC, Picard MH, Mady C. Assessment of diastolic function in endomyocardial fibrosis: value of flow propagation velocity. Artif Organs 2004;28(4): 343-6.         [ Links ]

23. Appleton CP, Galloway JM, Gonzalez MS, Gaballa M, Basnight MA. Estimation of left ventricular filling pressures using two-dimensional and Doppler echocardiography in adult patients with cardiac disease. Additional value of analyzing left atrial size, left atrial ejection fraction and the difference in duration of pulmonary venous and mitral flow velocity at atrial contraction. J Am Coll Cardiol 1993;22:1972-82.         [ Links ]

24. Basnight MA, Gonzalez MS, Kershenovich SC, Appleton CP. Pulmonary venous flow velocity: relation to hemodynamics, mitral flow velocity and left atrial volume, and ejection fraction. J Am Soc Echocardiogr 1991;4:547-58.         [ Links ]

25. Greenberg B, Chatterjee K, Parmley WW, Werner JA, Holly AN. The influence of left ventricular filling pressure on atrial contribution to cardiac output. Am Heart J 1979;98:742-51.         [ Links ]

26. Barretto AC, Mady C, Nussbacher A et al. Atrial fibrillation in endomyocardial fibrosis is a marker of worse prognosis. Int J Cardiol 1998;67:19-25.        [ Links ]

 

 

Correspondence to
Charles Mady
Av. Dr. Enéas C. Aguiar, 44
Cep 05403-000
São Paulo, SP - Brazil
E-mail: cmady@cardiol.br/ charles.mady@incor.usp.br

Received for publication: 02/16/04
Accepted for publication: 06/23/04
English version Stela Maris Costalonga